Daniel Krizek focuses on biotechnology investments ranging from venture capital stage to public equity.  Through his investment career, Mr. Krizek has financed over 120 emerging biotech companies across early and late venture rounds, with a focus on gene and cell therapies and oncology. He currently serves as Portfolio Manager at Surveyor Capital (a Citadel company). Prior to Surveyor, Mr. Krizek was as Director at Bain Capital, where he managed private and public investments in biotech, med-tech, and diagnostics sectors. Before Bain Capital, Mr. Krizek worked as a consultant at McKinsey & Co, where he advised companies in pharma, biotech, and med-tech. Mr. Krizek graduated from Stanford, and also holds CFA and CAIA designations.